1. Dietary supplementation with Bacillus subtilis C-3102 improves gut health indicators and fecal microbiota of dogs
    Daniele Cristina de Lima et al, 2020, Animal Feed Science and Technology CrossRef
  2. Prebiotic Isomaltooligosaccharide Provides an Advantageous Fitness to the Probiotic Bacillus subtilis CU1
    Romain Villéger et al, 2022, Applied Sciences CrossRef
  3. Analysis of microbial diversity and composition in small intestine during different development times in ducks
    Chunhong Zhu et al, 2020, Poultry Science CrossRef
  4. VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice
    Chun-Sai-Er Wang et al, 2018, World Journal of Gastroenterology CrossRef
  5. Evidence of the Anti-Inflammatory Effects of Probiotics and Synbiotics in Intestinal Chronic Diseases
    Julio Plaza-Díaz et al, 2017, Nutrients CrossRef
  6. Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation
    Michele Biagioli et al, 2020, Nutrients CrossRef
  7. A Minority Population of Non-dye-decolorizing Bacillus subtilis enhances the Azo Dye-decolorizing Activity of Enterococcus faecalis
    Yu Yamanashi et al, 2022, Microbes and Environments CrossRef
  8. Hydrogen peroxide production by lactobacilli promotes epithelial restitution during colitis
    Ashish K. Singh et al, 2018, Redox Biology CrossRef
  9. Bacillus As Potential Probiotics: Status, Concerns, and Future Perspectives
    Fouad M. F. Elshaghabee et al, 2017, Frontiers in Microbiology CrossRef
  10. The potential key genes and pathways associated with Wilms tumor in quest of proper candidates for diagnostic and therapeutic purposes
    Masoud Bitaraf et al, 2022, Scientific Reports CrossRef
  11. Effect of Combined Live Probiotics Alleviating the Gastrointestinal Symptoms of Functional Bowel Disorders
    Jin Shi et al, 2020, Gastroenterology Research and Practice CrossRef
  12. Enterococcus faecium R-026 combined with Bacillus subtilis R-179 alleviate hypercholesterolemia and modulate the gut microbiota in C57BL/6 mice
    Jinli Huang et al, 2023, FEMS Microbiology Letters CrossRef
  13. Non-lactic acid bacteria probiotics isolated from intestine or various circumstances
    Na-Kyoung Lee et al, 2024, Food Science and Biotechnology CrossRef
  14. Bacillus natto regulates gut microbiota and adipose tissue accumulation in a high-fat diet mouse model of obesity
    Pinggui Wang et al, 2020, Journal of Functional Foods CrossRef
  15. Secretome of Intestinal Bacilli: A Natural Guard against Pathologies
    Olga N. Ilinskaya et al, 2017, Frontiers in Microbiology CrossRef
  16. Hydroxysafflor yellow A protects against ulcerative colitis via suppressing TLR4/NF‐κB signaling pathway
    Zhibing Feng et al, 2022, Chemical Biology & Drug Design CrossRef
  17. Protective Role of a New Polysaccharide Extracted from Lonicera japonica Thunb in Mice with Ulcerative Colitis Induced by Dextran Sulphate Sodium
    Xiaonan Zhou et al, 2021, BioMed Research International CrossRef
  18. The mechanism of alopolysaccharide protecting ulceralive colitis
    Hu Lin et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  19. The Sporobiota of the Human Gut
    Muireann Egan et al, 2021, Gut Microbes CrossRef
  20. Probiotic Identity from Spore: Focus on Bacillus Probiotics
    Bhanuramanand K. et al, 2023, Probiotics, Prebiotics, Synbiotics, and Postbiotics CrossRef
  21. Bacillus subtilis RZ001 improves intestinal integrity and alleviates colitis by inhibiting the Notch signalling pathway and activating ATOH-1
    Yanru Li et al, 2020, Pathogens and Disease CrossRef
  22. The Use of Ascophyllum nodosum and Bacillus subtilis C-3102 in the Management of Canine Chronic Inflammatory Enteropathy: A Pilot Study
    Marco Isidori et al, 2021, Animals CrossRef
  23. Autoclaved Diet with Inactivated Spores of Bacillus spp. Decreased Reproductive Performance of Muc2−/− and Muc2+/− Mice
    Maryana V. Morozova et al, 2022, Animals CrossRef
  24. Probiotic characterization of Bacillus smithii: Research advances, concerns, and prospective trends
    Nan Zhao et al, 2024, Comprehensive Reviews in Food Science and Food Safety CrossRef
  25. Amelioration of the DSS‑induced colitis in mice by pretreatment with 4,4'‑diaponeurosporene‑producing Bacillus subtilis
    Yuchao Jing et al, 2017, Experimental and Therapeutic Medicine CrossRef
  26. Effects ofBacillus pumiluson growth performance, immunological indicators and gut microbiota of mice
    Nanchi Zhang et al, 2021, Journal of Animal Physiology and Animal Nutrition CrossRef
  27. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease
    Lingfeng Li et al, 2022, Frontiers in Immunology CrossRef
  28. Natural compounds as safe therapeutic options for ulcerative colitis
    Mukta Gupta et al, 2022, Inflammopharmacology CrossRef
  29. Upregulation of Intestinal Barrier Function in Mice with DSS-Induced Colitis by a Defined Bacterial Consortium Is Associated with Expansion of IL-17A Producing Gamma Delta T Cells
    Ming Li et al, 2017, Frontiers in Immunology CrossRef
  30. Effects of peanut meal extracts fermented by Bacillus natto on the growth performance, learning and memory skills and gut microbiota modulation in mice
    Xiaoyang Jiang et al, 2020, British Journal of Nutrition CrossRef
  31. Long-term and continuous administration of Bacillus subtilis during remission effectively maintains the remission of inflammatory bowel disease by protecting intestinal integrity, regulating epithelial proliferation, and reshaping microbial structure and function
    Yongqiang Liu et al, 2021, Food & Function CrossRef
  32. Microbial metabolites beneficial in regulation of obesity
    null Khushboo et al, 2022, Current Developments in Biotechnology and Bioengineering CrossRef
  33. Roseburia intestinalis and Its Metabolite Butyrate Inhibit Colitis and Upregulate TLR5 through the SP3 Signaling Pathway
    Guangcong Ruan et al, 2022, Nutrients CrossRef
  34. Endospores, sporulation, and germination
    Alba Romero-Rodríguez et al, 2024, Molecular Medical Microbiology CrossRef
  35. Effects of Bacillus subtilis C-3102 addition on nutrient digestibility, faecal characteristics, blood chemistry and faecal Lactobacilli spp., Enterococci spp., and Escherichia coli in healthy dogs
    Oguzhan Kahraman et al, 2023, Italian Journal of Animal Science CrossRef
  36. Dysbiosis and its Varied Impacts
    Rajani Sharma et al, 2023, The Gut Microbiota in Health and Disease CrossRef
  37. Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-α and IL-6 levels and functions and by rebalancing intestinal microbiota
    Chunsaier Wang et al, 2019, BMC Microbiology CrossRef
  38. Neuroimmunomodulation by gut bacteria: Focus on inflammatory bowel diseases
    Surbhi Aggarwal et al, 2021, World Journal of Gastrointestinal Pathophysiology CrossRef
  39. Conversations in the Gut: The Role of Quorum Sensing in Normobiosis
    Victor Markus et al, 2023, International Journal of Molecular Sciences CrossRef
  40. ROS-responsive hyaluronic acid hydrogel for targeted delivery of probiotics to relieve colitis
    Lijie Huang et al, 2022, International Journal of Biological Macromolecules CrossRef
  41. Rebuilding the Gut Microbiota Ecosystem
    Antonella Gagliardi et al, 2018, International Journal of Environmental Research and Public Health CrossRef
  42. Enterococcus faecium R0026 Combined with Bacillus subtilis R0179 Prevent Obesity-Associated Hyperlipidemia and Modulate Gut Microbiota in C57BL/6 Mice
    Jinli Huang et al, 2021, Journal of Microbiology and Biotechnology CrossRef
  43. Suppressed oncogenic molecules involved in the treatment of colorectal cancer by fecal microbiota transplantation
    Xing Han et al, 2024, Frontiers in Microbiology CrossRef
  44. Probiotic Microorganisms in Inflammatory Bowel Diseases: Live Biotherapeutics as Food
    Emanuelle Natalee Santos et al, 2024, Foods CrossRef